Anticoagulant therapy of thromboembolic diseases
Pons, E.R.; Diaz-Rivera, R.S.
Boletin de la Asociacion Medica de Puerto Rico 42(4): 223-227
1950
ISSN/ISBN: 0004-4849 PMID: 15411433 Document Number: 702827
Document emailed within 1 workday
Related Documents
Enrico, J.F. 1989: Prevention of recurrence of thromboembolic disease: maintenance of anticoagulant therapy Therapeutische Umschau. Revue Therapeutique 46(10): 732-738Kanaoka, Y.; Tanemoto, K.; Murakami, T.; Kuroki, K. 2000: Thromboembolic and bleeding complications in patients treated with oral anticoagulant therapy after mechanical heart valve prostheses implantation Kyobu Geka. Japanese Journal of Thoracic Surgery 53(9): 754-758
Lechat, P.; Lardoux, H.; Mallet, A.; Sanchez, P.; Derumeaux, G.; Lecompte, T.; Maillard, L.; Mas, J.L.; Mentré, F.; Pousset, F.; Lacomblez, L.; Pisica, G.; Solbes-Latourette, S.; Raynaud, P.; Chaumet-Riffaud, P. 2000: Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. a randomized trial (FFAACS) Therapie 55(6): 681-689
Yao, H.; Miyamoto, T.; Yamashita, K.; Mukai, M.; Wada, T.; Yamamura, M.; Nakagawa, T.; Ryomoto, M. 2000: Necessity of permanent anticoagulant therapy for isolated mitral valve replacement with bioprosthetic heart valve to prevent the postoperative thromboembolic complications Kyobu Geka. Japanese Journal of Thoracic Surgery 53(4): 337-340
Heine, H.; Schmidt, H.; Mach, H.; Jaruszewski, H. 1971: Anticoagulant therapy and prophylaxis in arterial vascular diseases Das Deutsche Gesundheitswesen 26(19): 861-868
Latallo, Z.S.; Malanowicz, W. 1970: Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants Kardiologia Polska 13(4): 351-358
Boscaro, M.; Sonino, N.; Scarda, A.; Barzon, L.; Fallo, F.; Sartori, M.T.; Patrassi, G.M.; Girolami, A. 2002: Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome Journal of Clinical Endocrinology and Metabolism 87(8): 3662-3666
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Misharev, O.S.; Dmitriev, V.V. 1982: Anticoagulant therapy of hemostatic disorders in suppurative septic diseases in children Vestnik Khirurgii Imeni I. I. Grekova 129(10): 130-134
Holmström, H.; Rootwelt, T. 1999: Thromboembolic diseases in children Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 119(20): 3006-3012
Breddin, K. 1972: Acetylsalicylic acid in thromboembolic diseases Deutsche Medizinische Wochenschrift 97(37): 1403-1404
Hardegger, T.; Lämmle, B. 1992: Thromboembolic diseases from the hematologic viewpoint: 13 case examples Therapeutische Umschau. Revue Therapeutique 49(12): 859-866
Kosaka, T.; Nagase, M.; Suzuki, Y.; Kobayashi, N. 1980: Anticoagulant therapy in combination with pulse therapy--about 12 nephritic patients with nephrotic syndrome-- Nihon Jinzo Gakkai Shi 22(8): 1095-1111
Römer, T. 1994: Hysteroscopic therapy of recurrent hemorrhage in long-term anticoagulant therapy Zentralblatt für Gynakologie 116(12): 695-696
Strozzi, C.; Malin, L.; Cocco, G.; Longhini, C. 1977: Thrombolytic treatment of peripheral thromboembolic vascular diseases using streptokinase La Clinica Terapeutica 83(2): 135-150
Husted, S.E.; Nielsen, H.K.; Krusell, L.R.; Faergeman, O. 1989: Acetylsalicylic acid in the treatment of arterial thromboembolic diseases. 1. Pharmacologic aspects Ugeskrift for Laeger 151(25): 1597-1599
Carroll, W.E.; Jackson, R.D. 1999: Modified anticoagulant therapy factor and international normalized ratio in patients in an unstable coagulation state with respect to warfarin therapy Research Communications in Molecular Pathology and Pharmacology 105(3): 262-270
Pineo, G.F.; Hull, R.D. 2004: Dalteparin: pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseases European Journal of Medical Research 9(4): 215-224
Joist, J.H. 1970: Drug inhibition of blood platelet function. A new trend in the prevention of thromboembolic diseases Die Medizinische Welt 27: 1247-1251
Holcenberg, J.S.; Veltkamp, J.J. 1970: Drug therapy. V. Oral anticoagulant therapy Northwest Medicine 69(6): 421-424